76 FR 54 pgs. 15328-15329 - National Institute on Drug Abuse; Notice of Closed Meetings
Type: NOTICEVolume: 76Number: 54Pages: 15328 - 15329
FR document: [FR Doc. 2011-6584 Filed 3-18-11; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; GISTE, the Geospatial Information Systems Tool (5558).
Date: April 18, 2011.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 301-402-6626, gm145a@nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Research Works: Enrollment Workflow (2219).
Date: April 28, 2011.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-9550, (301) 435-1439, lf33c@nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA's Science Meetings Logistical Support (1144).
Date: May 3-4, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-9550, (301) 435-1439, lf33c@nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Research Support Services for NIDA AIDS Research Program (1207).
Date: May 5, 2011.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-9550, (301) 435-1439, lf33c@nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Development & Manufacture of Pharmaceutical Products/Addiction Treatment (8899).
Date: May 24, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-9550, (301) 435-1439, lf33c@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: March 15, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-6584 Filed 3-18-11; 8:45 am]
BILLING CODE 4140-01-P